CAREERS


If you are interested in joining a cutting-edge biotechnology company that is working to develop treatments to fight life-threatening diseases, and wish to know more about opportunities at Xenikos, please send your resumé and cover letter to info[at]xenikos.com.

Vacancies


Bioanalytical Scientist (0,8 - 1,0 FTE)

Biotechnology, Biochemistry
Nijmegen, February 4th, 2019
Application deadline: February 25th, 2019

Read more...
Xenikos B.V. is looking for a Bioanalytical Scientist to strengthen its team as the Company prepares to enter phase 3 clinical testing.

Responsibilities
As a Bioanalytical Scientist at Xenikos, you will manage the development, implementation and validation of analytical methods, specifically for biologics. The company operates in a semi-virtual mode, not running its own laboratories or plants, so your work will also include the selection, qualification and oversight of third-party analytical service providers.

You will coordinate the stability programs and conduct product comparability assessments, author and review the Standard Operating Procedures (SOPs), technical documents, protocol and reports; and you will conduct OOS, Non-conformance and root cause investigations. Other responsibilities include: maintaining records according to good documentation practices; adhering to the Company’s EHS and Quality policies and procedures; conducting trend analyses; writing regulatory submission documents; and the rational and risk-based selection of analytical methods needed to support manufacturing. You will be expected to manage your own work schedule effectively and efficiently and to keep up to date with the latest scientific and technical developments.

Work environment
Founded in 2009, Xenikos is a Biotech company operating from Nijmegen, the Netherlands, developing innovative new immunotherapies based on conjugated antibodies. This novel therapeutic approach helps reset the immune system in patients who have a severe immune disease or developed post-transplantation rejection. Our flagship product, T-Guard®, is now ready to enter Phase 3 testing for the second-line treatment of steroid-resistant acute graft-versus-host disease (SR-aGVHD) a life-threatening condition common in patients following hematopoietic stem cell transplantation.

To conduct this trial in the U.S., Xenikos partnered with the Blood and Marrow Transplant Clinical Trials Network (BMT CTN), funded by the National Heart, Lung, and Blood Institute and the National Cancer Institute, both part of the National Institues of Health. BMT CTN includes leading transplant centers in the United States and, through the NIH, will provide co-funding for the T-Guard trial. Other potential applications for T-Guard® include transplant-related rejection, acute solid-organ rejection, and various autoimmune diseases.

Xenikos consists of a small team, with open lines of communication, where your input is valued. You will be working in a close-knit team of professionals, in an inspiring and dynamic working environment, where you will be helping to save patient’s lives. If you dream of a job where you are at the forefront of today’s science and where your contribution can really make a difference, then Xenikos is for you.

What we expect from you

Education & Experience:
• A University degree in biochemistry or a related discipline;
• Proven affinity with analytical development;
• Relevant working experience, preferably within the biopharmaceutical industry;
• Thorough understanding of biopharmaceuticals and relevant CMC development aspects, in particular stability studies and comparability exercises;
• Broad experience with bioanalytical techniques.

Profile:
• A pioneering mindset;
• Ability to deal with complexity and conflicting interests;
• Builder of relationships within an international collaboration network;
• Ability to change perspective between the big picture and technical detail;
• Language skills: English and Dutch, level C1/C2;
• Team player who can think on their feet, is capable of working independently and is assertive, well-organized and helpful.

What we have to offer
• An employment contract for 0,8 – 1,0 FTE;
• A competitive salary, based on a 32/40-hour working week, plus an 8% holiday allowance;
• Duration of the contract is negotiable;
• An inspiring and innovative working environment, with room for personal growth;
• The opportunity to help bring a potentially life-saving treatment to patients that currently have no alternative treatment option.

Additional information
The starting date of the employment contract is open to discussion, but preferably as soon as possible.
We are an equal opportunity employer, and as such encourage applications from women and minorities.

Questions?
For more information about this vacancy, please contact:
Maarten Frijlink, COO
Telephone: +31 24 3000100
E-mail: info[at]xenikos.com
See www.xenikos.com for more information about Xenikos and T-Guard®.

Interested?
Please send your application to info[at]xenikos.com. Make sure to include a letter of motivation, as well as your resumé. Incomplete applications will not be considered.

Application Deadline
Please send in your application by February 25th, 2019.

Apply

Bioprocess Technologist (0,8 - 1,0 FTE)

Process Technology, Biotechnology, Biochemistry, Industrial Microbiology
Nijmegen, February 4th, 2019
Application deadline: February 25th, 2019

Read more...
Xenikos B.V. is looking for a Bioprocess Technologist to strengthen its team as the Company prepares to enter phase 3 clinical testing.

Responsibilities
As a Bioprocess Technologist at Xenikos, you will manage the development, implementation and validation of biopharmaceutical manufacturing processes. The company operates in a semi-virtual mode, not running own laboratories or plants, so your work will also include the selection, qualification and oversight of third-party service providers.

You will author and review the Standard Operating Procedures (SOPs), technical documents, protocols and reports; and you will conduct OOS, Non-conformance and root cause investigations. Other responsibilities include: maintaining records according to good documentation practices; adhering to the Company’s EHS and Quality policies and procedures; conducting trend analyses; writing regulatory submission documents; and the rational and risk-based selection of analytical methods needed to support manufacturing. You will be expected to manage your own work schedule effectively and efficiently and to keep up to date with the latest scientific and technical developments.

Work environment
Founded in 2009, Xenikos is a Biotech company operating from Nijmegen, the Netherlands, developing innovative new immunotherapies based on conjugated antibodies. Our flagship product, T-Guard® helps reset the immune system in patients who have a severe immune disease or developed post-transplantation rejection. This therapeutic approach is now ready to enter Phase 3 testing for the second-line treatment of steroid-resistant acute graft-versus-host disease (SR-aGVHD) a life-threatening condition common in patients following hematopoietic stem cell transplantation.

To conduct this trial in the U.S., Xenikos partnered with the Blood and Marrow Transplant Clinical Trials Network (BMT CTN), funded by the National Heart, Lung, and Blood Institute and the National Cancer Institute, both part of the National Institues of Health. BMT CTN includes leading transplant centers in the United States and, through the NIH, will provide co-funding for the T-Guard trial. Other potential applications for T-Guard® include transplant-related rejection, acute solid-organ rejection, and various autoimmune diseases.

Xenikos consists of a small team, with open lines of communication, where your input is valued. You will be working in a close-knit team of professionals, in an inspiring and dynamic working environment, where you will be helping to save patient’s lives. If you dream of a job where you are at the forefront of today’s science and where your contribution can really make a difference, then Xenikos is for you.

What we expect from you

Education & Experience:
• A University degree in bio(process)technology, biochemistry, industrial microbiology or a related discipline;
• Proven affinity with, and broad understanding of biopharmaceutical manufacturing;
• Basic understanding of GMP requirements and, in particular, process validation aspects;
• Relevant working experience, preferably within the biopharmaceutical industry;
• Thorough understanding of relevant CMC development aspects and pertinent regulatory processes.


Profile:
• A pioneering mindset;
• Ability to deal with complexity and conflicting interests;
• Builder of relationships within an international collaboration network;
• Ability to change perspective between the big picture and technical detail;
• Language skills: English and Dutch, level C1/C2;
• Team player who can think on their feet, is capable of working independently and is assertive, well-organized and helpful.

What we have to offer
• An employment contract for 0,8 – 1,0 FTE;
• A competitive salary, based on a 32/40-hour working week, plus an 8% holiday allowance;
• Duration of the contract is negotiable;
• An inspiring and innovative working environment, with room for personal growth;
• The opportunity to help bring a potentially life-saving treatment to patients that currently have no alternative treatment option.

Additional information
The starting date of the employment contract is open to discussion, but preferably as soon as possible.
We are an equal opportunity employer, and as such encourage applications from women and minorities.

Questions?
For more information about this vacancy, please contact:
Maarten Frijlink, COO
Telephone: +31 24 3000100
E-mail: info[at]xenikos.com
See www.xenikos.com for more information about Xenikos and T-Guard®.

Interested?
Please send your application to info[at]xenikos.com. Make sure to include a letter of motivation, as well as your resumé. Incomplete applications will not be considered.

Application Deadline
Please send in your application by February 25th, 2019.

Apply
//]]>